Healthcare - Biotechnology - NASDAQ - US
$ 86.83
-6.31 %
$ 10.8 B
Market Cap
-18.88
P/E
BALANCE SHEET
1.41 B
ASSETS
167 M
LIABILITIES
1.24 B
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Vaxcyte, Inc.
| Current Assets | 1.1 B |
| Cash & Short-Term Investments | 1.08 B |
| Receivables | 0 |
| Other Current Assets | 15.7 M |
| Non-Current Assets | 312 M |
| Long-Term Investments | 163 M |
| PP&E | 111 M |
| Other Non-Current Assets | 38.7 M |
| Current Liabilities | 145 M |
| Accounts Payable | 14.6 M |
| Short-Term Debt | 14.2 M |
| Other Current Liabilities | 117 M |
| Non-Current Liabilities | 22.1 M |
| Long-Term Debt | 22.1 M |
| Other Non-Current Liabilities | 0 |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 397.5 | 834.7 | 69.0 | 386.2 | 59.0 | 66.1 | 36.1 |
| Short Term Investments | 682.8 | 96.7 | 177.0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | (1.0) | (1.2) | (0.3) | (0.2) | 0 | 0 |
| Other Current Assets | 15.7 | 5.3 | 9.2 | 2.5 | 2.7 | 0.6 | 0.2 |
| Total Current Assets | 1 096.0 | 942.6 | 256.3 | 389.0 | 61.7 | 66.7 | 36.3 |
| PP&E | 110.6 | 31.6 | 35.9 | 3.3 | 3.4 | 3.4 | 3.0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 162.7 | 26.5 | 27.1 | 0 | 0 | 0 | 0 |
| Other Long Term Assets | 38.7 | 5.4 | 5.0 | 0.6 | 0.6 | 0.7 | 0.3 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 1 407.9 | 1 006.2 | 324.3 | 392.8 | 65.7 | 70.8 | 39.6 |
| LIABILITIES | |||||||
| Accounts Payable | 14.6 | 9.8 | 6.8 | 29.8 | 3.4 | 2.8 | 1.8 |
| Short Term Debt | 14.2 | 11.8 | 10.6 | 0 | 0.2 | 0.3 | 0.3 |
| Other Current Liabilities | 116.5 | 18.9 | 11.4 | 17.1 | 7.5 | 3.6 | 2.2 |
| Total Current Liabilities | 145.3 | 40.5 | 28.7 | 46.9 | 11.1 | 6.7 | 4.3 |
| Long Term Debt | 22.1 | 12.0 | 11.5 | 0 | 0 | 0.2 | 4.2 |
| Deferred Tax Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0 | 9 K | 96 K | 0.1 | 161.0 | 121.7 | 0.2 |
| Total Liabilities | 167.4 | 52.6 | 40.3 | 47.0 | 172.1 | 128.5 | 8.7 |
| EQUITY | |||||||
| Common Stock | 98 K | 82 K | 56 K | 54 K | 7 K | 6 K | 6 K |
| Retained Earnings | (924.4) | (522.1) | (298.6) | (198.6) | (109.3) | (59.1) | (29.6) |
| Other Accumulative Comprehensive Income/Loss | 0.2 | (0.4) | (0.2) | (392.8) | (160.3) | (1.8) | 0 |
| Total Equity | 1 240.5 | 953.6 | 284.0 | 345.8 | (106.4) | (57.7) | 30.9 |
| Total Liabilities and Equity | 1 407.9 | 1 006.2 | 324.3 | 392.8 | 65.7 | 70.8 | 39.6 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 97.2 | 64.9 | 51.9 | 51.1 | 48.9 | 25.6 | 3.6 |